These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15023450)

  • 1. Modulation of combined-release behaviors from a novel "tablets-in-capsule system".
    Li YH; Zhu JB
    J Control Release; 2004 Mar; 95(3):381-9. PubMed ID: 15023450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The release behavior of the combined system of diltiazem hydrochloride delayed-onset sustained-release pellets and modeling by mathematics method].
    Chen SJ; Zhu JB
    Yao Xue Xue Bao; 2005 Jul; 40(7):606-10. PubMed ID: 16196265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on combined release behaviors of versatile mini-tablets in capsule systems and fittings of their mathematical model].
    Li YH; Zhu JB; Chen SJ; Jia YJ
    Yao Xue Xue Bao; 2004 Jun; 39(6):472-6. PubMed ID: 15491109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel system for three-pulse drug release based on "tablets in capsule" device.
    Li B; Zhu J; Zheng C; Gong W
    Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of wet granulation on the erosion behaviour of an HPMC-lactose tablet, used as a rate-controlling component in a pulsatile drug delivery capsule formulation.
    McConville JT; Ross AC; Chambers AR; Smith G; Florence AJ; Stevens HN
    Eur J Pharm Biopharm; 2004 May; 57(3):541-9. PubMed ID: 15093604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulsatile drug-delivery systems.
    Bussemer T; Otto I; Bodmeier R
    Crit Rev Ther Drug Carrier Syst; 2001; 18(5):433-58. PubMed ID: 11763497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation of nifidipine pulsatile release tablets].
    Zhang Y; Zhang ZR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):261-3. PubMed ID: 15071935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
    Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
    Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel pH-dependent gradient-release delivery system for nitrendipine II. Investigations of the factors affecting the release behaviors of the system.
    Yang M; Cui F; You B; Wang L; Yue P; Kawashima Y
    Int J Pharm; 2004 Nov; 286(1-2):99-109. PubMed ID: 15501006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of scoring to induce reproducible drug delivery from osmotic pulsatile tablets.
    Rahemba TR; Bell S; Connolly EK; Waterman KC
    Pharm Dev Technol; 2009; 14(5):548-55. PubMed ID: 19552560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
    Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ
    J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of verapamil hydrochloride core-in-cup tablets with double-pulsatile and multi-phasic release].
    Li CJ; Zhu JB; Yu WY
    Yao Xue Xue Bao; 2008 Jun; 43(6):652-6. PubMed ID: 18822971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel remote controlled capsule for site-specific drug delivery in human GI tract.
    Xitian P; Hongying L; Kang W; Yulin L; Xiaolin Z; Zhiyu W
    Int J Pharm; 2009 Dec; 382(1-2):160-4. PubMed ID: 19716870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthan and galactomannan (from M. scabrella) matrix tablets for oral controlled delivery of theophylline.
    Vendruscolo CW; Andreazza IF; Ganter JL; Ferrero C; Bresolin TM
    Int J Pharm; 2005 May; 296(1-2):1-11. PubMed ID: 15885450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained-release methylphenidate: new preparations. New pharmaceutical forms: a slight advantage for a small number of children.
    Prescrire Int; 2004 Dec; 13(74):203-6. PubMed ID: 15612099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of channeling agents on the release pattern of theophylline from kollidon SR based matrix tablets.
    Ibn Razzak MS; Khan F; Hossain M; Khan MZ; Azad MA; Reza MS
    Pak J Pharm Sci; 2009 Jul; 22(3):303-7. PubMed ID: 19553179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups.
    Aleksovski A; Dreu R; Gašperlin M; Planinšek O
    Expert Opin Drug Deliv; 2015 Jan; 12(1):65-84. PubMed ID: 25200881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of experimental design methodology in development and optimization of drug release method.
    Kincl M; Turk S; Vrecer F
    Int J Pharm; 2005 Mar; 291(1-2):39-49. PubMed ID: 15707730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.